Policy options for sustainable access to off-patent antibiotics in Europe

2024/11/25 by Димитра Пантели, Michael Anderson, Thomas Fieldman +5 · 1 voice · 1 citation
Economics, Econometrics and Finance · Immunology and Microbiology · #Antibiotic Use and Resistance #Health Systems, Economic Evaluations, Quality of Life #Pharmaceutical Economics and Policy

paper · pdf · doi:10.1038/s44259-024-00061-4

openalex publication_date 2024/11/25 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/15

Abstract

Securing sustainable access to existing antibiotics optimises agent choice for individual treatments and is crucial to curb antibiotic resistance. Access to antibiotics is often restricted in many countries, due to general market unavailability or episodic shortages. This article outlines key policy options to maintain availability of existing antibiotics and enhance antibiotic supply chain resilience focusing on the perspectives of European Union (EU) and European Economic Area (EEA) institutions and member states.

Cited by

• From 60 Causes to 10 Solutions Against Antibiotics Shortages in Sweden: Platinea’s Approach to Developing Policy Interventions

Discussions

• Ensuring access to off-patent antibiotics is crucial, yet barriers like shortages and supply issues persist. Proposed solutions include regulatory reforms, improved procurement, standardized formulati [bsky, 4 points, 0 comments]

Related

• From 60 Causes to 10 Solutions Against Antibiotics Shortages in Sweden: Platinea’s Approach to Developing Policy Interventions
• The challenge of antimicrobial resistance: What economics can contribute
• Adaptation of the WHO AWaRe (Access, Watch, Reserve) antibiotic classification to support national antimicrobial stewardship priorities in the UK: findings from a modified Delphi approach to achieve expert consensus
• Antimicrobial resistance and antimicrobial stewardship programmes: benefiting the patient or the population?
• Antimicrobial Resistance (AMR)